TNFRSF9 and atherosclerosis: Furthermore, Lei et al. reported that the treatment of atherosclerosis with phthalides in LC in the ApoE−/− mouse model is related to the inhibition of NF-κB and AP-1 expressions and as well as suppression of CD137 level which is considered as a biomarker of atherosclerosis [28].